A Message From Lap-Chee Tsui
As president of the Academy of Sciences of Hong Kong, I invite you to engage with me and my co-hosts, Venkatraman Ramakrishnan, president of the Royal Society of London, Marcia McNutt, president of the U.S. National Academy of Sciences, and Victor Dzau, president of the U.S. National Academy of Medicine, as we prepare for the Second International Summit on Human Genome Editing. The summit will take place on Nov. 27-29, 2018, at the University of Hong Kong.
Since the first international summit was held in 2015 in Washington, D.C., research on human genome editing has continued to advance rapidly. However, many questions remain about the science, application, ethics, and governance of human genome editing. Of particular concern is the possibility of heritable genome editing, which would alter the human germline, and applications for purposes other than to treat disease or disability.
The Second International Summit on Human Genome Editing will continue to advance the global dialogue on these issues by bringing together a broad range of stakeholders — including researchers, ethicists, policymakers, patient groups, and representatives from science and medical academies and organizations worldwide — to explore topics including: 1) potential benefits and risks inherent in conducting genome editing research and in considering clinical applications; 2) ethical and cultural perspectives; 3) legal, regulatory, and policy considerations; and 4) public outreach and engagement.
Along with my co-hosts, I look forward to welcoming representatives from around the world to Hong Kong this fall to continue this critical international discussion.